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Abstract
Manganese is an essential trace element found in humans, which aids in several processes
including brain and nerve function, glucose metabolism, calcium absorption, and bone formation
and homeostasis. Specifically, bone homeostasis utilizes osteoblasts and osteoclasts, cells which
function to build and reabsorb bone respectively, as well as chondrocytes, cells which aid in
endochondral ossification. Chondrocytes deposit extracellular matrix components, such as
aggrecan, collagen, and proteoglycans, that provide the necessary scaffold for osteoblasts to
synthesize and mineralize bone. Activation of the rapamycin (mTOR) pathway influences the
regulation of several cellular processes, such as skeletal development and bone homeostasis. In
this study, it was hypothesized that Manganese Chloride (MnCl 2) treatments would activate the
RHEB/mTOR pathway in the murine ATDC5 cell line to enhance chondrocyte maturation and
protection against degradation. To test this hypothesis, the effects of MnCl 2 treated ATDC5 cells
were measured through cellular proliferation, alkaline phosphatase activity, calcium deposition,
proteoglycan concentrations, and gene expression at timepoints. Our results found that MnCl 2
dose dependently decreased chondrocyte proliferation and proteoglycan deposition, while
increasing alkaline phosphatase activity and calcium deposition.

Keywords: Manganese chloride, chondrogenesis, chondrocyte, hypertrophic cartilage,
endochondral ossification, osteoarthritis, mTOR pathway, RHEB, alkaline phosphatase,
proteoglycan
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Introduction
Manganese Chloride
Manganese is an essential trace element found in the human diet. This element aids in
carbohydrate, protein, and cholesterol metabolism (1). Not only does it support normal brain and
nerve function, but manganese also aids in the formation of connective tissues, calcium
absorption, and bone matrices (1, 2). Studies have shown that manganese functions as an
antioxidant factor and enzyme cofactor for enzyme superoxide dismutase (SOD), which allows
the body to fight against harmful free radicals (1). Manganese also been shown to aid Vitamin K
in blood clotting and wound healing (3).
Cartilage Formation / Chondrogenesis
Chondrocytes are responsible for synthesizing extracellular matrix (ECM) components,
collagen, specifically Collagen Type II (Col2a1), and proteoglycans, all which provide the
necessary scaffold for bone synthesis (4). Without healthy chondrocytes secreting these
components, matrix degradation occurs, initiating and progressing into diseases such as
Osteoarthritis (OA) down the line (4). Chondrogenesis begins with the condensation of
mesenchymal cells (MSC), differentiation into chondroprogenitors, maturation into
chondroblasts and chondrocytes, and finally terminal differentiation into hypertrophic
chondrocytes. During this process, chondrocytes express Collagens I-X as they mature (Figure
1) (4). The presence of important transcription factors, such as SRY-box 9 protein (SOX9) and
Runt-related transcription factor 2 (RUNX2), allow for smooth chondrocyte development, and
are responsible for MSC differentiation and hypertrophic chondrocyte stimulation, respectively
(5). Bone morphogenic proteins (BMPs) regulate the expression of both SOX9 and RUNX2 (5).
1

Extracellular matrix proteins, such as Col1 and Col2a1, are secreted between MSC condensation
and chondroprogenitor differentiation, and are responsible for tissue strengthening and matrix
stabilization (6). Col2a1 comprises 90% of ECM collagen, creating a fibrous network with
proteoglycan-like aggrecans (6). Chondrocytes deposit cartilage at the ends of bones, undergoing
a cycle of proliferation, hypertrophy, and apoptosis to allow endochondral ossification, the
process wherein hypertrophic cartilage is reabsorbed and replaced by bone, to occur (7).

Note: Figure made by Isabella K. Somera using BioRender.com
Figure 1: Stages of Chondrogenesis
Chondrogenesis begins with MSC condensation, which is controlled by
transcription factor, SOX9. During this stage, Col2a1 is expressed in the ECM.
MSCs proliferate and differentiate into chondroprogenitors and mature into hypertrophic
chondrocytes, which is controlled by RUNX2. Hypertrophic chondrocytes will then begin
endochondral ossification. BMPs control both SOX9 and RUNX2 expression.
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Manganese Chloride and Chondrogenesis

Although the pathway of activation in the body is still unclear, manganese’s effect on
chondrogenesis can be observed through the delay of articular cartilage regeneration and
cartilage repair (1). Additionally, manganese aids in the synthesis of glycosaminoglycans,
proteoglycans, Col2a1, regulation of cartilage matrix metabolism, scavenging oxygen free
radical and antioxidants, reducing oxidative stress, and protecting the ECM (1). The deficiency
of manganese disrupts glycosaminoglycan biosynthesis and chondrogenesis, leading to cartilage
dysplasia and lack of endochondral bone formations (1, 8). According to Cue-Yue Wang, who
studied the deficiencies of this trace element in the cartilaginous dystrophy disease, avian tibial
dyschondroplasia (TD), saw that the lack of manganese disrupts normal chondrocyte growth in
the tibial growth plate and lowers protein expression of Col2a1 and Collagen Type X (9).
Additionally, Wang performed histological staining which illustrated atypical chondrocyte
morphologies and arrangements, that were associated with inhibited endochondral ossification
(9). In another study, manganese deficiency on chondrocyte development of the tibial growth
plate was conducted on Arbor Acres chicks. In this study, manganese deficient chicks showed
bone perosis, resulting in enlarged distal tibias and distorted proximal tibias (10).
Histopathological observations saw reduced proliferation zones of manganese deficient growth
plates, as reflected in the abnormal tibial growth (10). Jian Wang also reported increased
apoptosis of hypertrophic chondrocytes due to manganese deficiency (10).
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Osteoarthritis
Osteoarthritis (OA) is a chronic degenerative joint disease, which specifically deteriorates
the structure of articular cartilage found at the ends of bones over time. Over 32.5 million US
adults are affected with OA, and experience symptoms of pain, stiffness, and immobility due to
aging, mechanical stresses, and localized inflammation (11,12). There is no specific cure for this
disease, but various treatments to relieve patient including nonsteroidal anti-inflammatory drugs
(NSAIDS), cortisone or lubrication injections, and surgical measures, such as knee osteotomies
(11, 13). Unfortunately, these nonsurgical and reconstructive surgical therapies do not effectively
resolve OA as cartilage has low levels of perfusion, or vascularity, which restrict its ability to
regenerate and self-repair (14, 15). Current gene and regenerative therapies have sought to solve
this issue. For example, autologous chondrocyte implantation (ACI) is a current medical
treatment which aims to rebuild articular tissues (12). Although ACI shows promise for cartilage
tissue regeneration, ACI requires specific amounts of clinical-grade chondrocytes for successful
therapy (12). In vitro cultures are necessary in the transplantation process, but also present
challenges regarding the replication of physiological human chondrocyte activity (12). In vitro
chondrocytes cultures face challenges of senescence, dedifferentiation, and oxidative stresses
with exposure to reactive oxygen species with every cell passage (12). Senescent chondrocytes
enter a state of irreversible growth arrest and dedifferentiate with phenotypic changes from
polygonal to a fibroblastic morphology (12). Additionally, less aggrecan and Col2a1 are
expressed, while increased hypertrophic markers, such as Col10a1, are shown (12). Reactive
oxygen species (ROS) and cell senescence inhibit proteoglycan synthesis and growth of the
ECM, and overtime, can adversely affect cartilage (4,7).
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Osteoarthritis & RHEB

Ras homolog enriched in brain (RHEB) is a guanosine triphosphate (GTPase), which
belongs to the Ras superfamily, and aids in the regulation of cell growth, proliferation, and
differentiation (16). RHEB targeting has been able to increase chondrogenic markers in healthy
chondrocytes as well as degenerated OA chondrocytes (16). RHEB is essential in the activation
of mammalian target of rapamycin (mTOR), a serine/threonine kinase responsible for protein
synthesis, growth, and autophagy (Figure 2) (16,17). mTOR has two subunits: mTORC1 and
mTORC2 (16). mTORC1 monitors signals of growth factors such as Insulin/Insulin Growth
Factor-1 (IGF-1), oxygen and energy levels for cell growth and metabolism (16). RHEB can
directly bind to mTORC1 and stimulate this activity (16). Conversely, mTORC2 controls
proliferation and survival, but is activated through mechanical stress and ribosomes in vitro (16).
mTORC1 has been said to aid in the regulation of cartilage development, primarily through its
disruption, which impaired chondrogenesis (16). In terms of OA, mTOR appears to be
overexpressed in human, rodent, and canine experiments (17). The upregulation of mTOR
caused a direct downstream modulation of autophagy in articular cartilage homeostasis (17).

5

Note: Figure made using BioRender.com

Figure 2: mTOR Signaling Pathway
The targeting of RHEB has been shown to upregulate expression of chondrocyte
markers in both healthy and OA chondrocytes. RHEB is responsible for activating
mTOR subunit, mTORC1, which leads to cell growth and proliferation.
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Manganese Chloride and RHEB

Little is known regarding manganese and RHEB, but manganese appears to activate and
regulate TORC1 in yeast (mTORC1 in mammals) for manganese homeostasis (17). Interestingly,
manganese could activate the Protein Kinase B (AKT) / Tuberous Sclerosis Complex 2 (TSC2)
pathway, leading to RHEB and mTOR activation (18). Additionally, the activity of Kisspeptin-1
(KISS1) was explored due to activation of the AKT/RHEB/mTOR pathway (18). Therefore, in
this present study, the interactions between manganese chloride, RHEB, and mTOR will be
explored in hopes to find a potential target for gene therapy for osteoarthritis. We hypothesized
that manganese chloride will have a positive effect on chondrocyte viability, alkaline
phosphatase (ALP) activity, calcium deposition, and proteoglycan deposition.
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Methodology:
Cell Culture
ATDC5 murine chondrocyte cells were gifted from the O’Connor Lab (Rutgers New
Jersey Medical School, Newark, NJ), and were cultured in growth medium containing
Delbecco’s Modified Eagle’s Medium (DMEM F12 50/50) (Corning, Corning NY),
supplemented with 5% fetal bovine serum (FBS) (Atlanta Biologics), 1%
Penicillin/Streptomycin (Corning, Corning NY), 1% Glutamate (Corning, Corning NY), 1%
Transferrin (Invitrogen, Waltham MA) and 1% Sodium Selenite (Sigma-Aldrich, Burlington
MA). Cells were stored in an incubator of 5% CO2 at 37℃, and were passaged up to 8 times.
Seedings of 100,000 cells per well (30% density) were completed in 12-well plates.
Chondrogenesis was maintained with frequent media exchanges with differentiation medium.
The differentiation medium consisted of a positive control of 10μg/mL of insulin (SigmaAldrich, Burlington MA), negative control of basal media, and increasing concentrations of
MnCl2 (Sigma-Aldrich, Burlington MA) at low dose (0.3μM), medium dose (3μM), and high
dose (30μM). Media exchanges occurred every 2-3 days, and cell media was collected posttreatment on Days 1, 3, 7, 10, 14, 17, and 21.

MTT Assay (Cellular Viability and Proliferation)
To evaluate cellular proliferation induced by MnCl2, an MTT Assay Kit (Abcam,
Cambridge UK) was completed. First, ATDC5 cells were plated at a density of 20,000 cells in a
96-well plate and were left to incubate at 37℃. Treatments of insulin and increasing doses of
MnCl2 were added 24 hours after plating. MTT solution was added after 24 hours of treatment
left to incubate at 37℃ for 3 hours. Following incubation, DMSO was added to each well and
8

again was left to incubate for 2-6 hours. Absorbances of the plates were read in triplicate at
570nm. After the data was normalized, the Percent Viability was calculated using the equation:

Alkaline Phosphatase (ALP) Assay
To study ALP activity, an indicator of the presence of osteoblasts and formation of new
bones, an ALP Assay (Abcam, Cambridge UK) was performed. The media collected from Days
1, 3, 7, 10, and 14 were used to quantify ALP activity. Standards, samples diluted with Assay
Buffer, and sample background controls were added in triplicate to a 96-well plate. After, 5 mM
pNPP solution was added to the sample and background control wells with the ALP enzyme
added to the standard wells. Plates were left to incubate at 25°C for 60 minutes on a shaker and
protected from light. Absorbance was read at 405nm. A standard curve was used to generate
concentrations of ALP.

Alizarin Red Staining (Calcium Deposition)
To assess calcium deposition within the cell cultures, an Alizarin Red Stain (ARS), was
performed. This anthraquinone dye can be extracted from the stained monolayer of cells and can
be used in order to quantify calcification. At day 14, the cells were gently washed with 1x
Phosphate Buffer Saline (PBS) (ThermoFisher, Waltham MA) and fixed in 4% formaldehyde for
15 minutes at room temperature. After the fixative was aspirated, the cells were washed 3 times
with diH20 and stained with 1mL of 40 mM ARS per well. The plates were then incubated at
room temperature and left on plate shaker for 25 minutes. Then, the dye was removed and
washed 5 times with diH20 and imaged using the Accu-Scope Microscope (ACCU-SCOPE Inc.,
9

Commack NY) Then, 10% acetic acid was added to each well and incubated at room temperature
for 30 minutes with shaking. The cells were then collected with a cell scraper and transferred in
the 10% acetic acid to a microcentrifuge tube. After, the tubes were vortexed, heated at 85℃ for
10 minutes, and placed on ice for 5 minutes. The slurry was then centrifuged at 20,000g for 15
minutes and the supernatant was transferred and combined with 10% ammonium hydroxide
(WVR, Randor PA) to neutralize the acid in a new tube. Samples were aliquoted in triplicate into
a flat-bottom 96-well plate and measured at an absorbance of 405nm using the VarioSkan Plate
Reader (ThermoFisher, Waltham MA). An ARS standard curve was generated to calculate the
concentrations of calcium deposition of the samples.

Glacial Blue Assay (Proteoglycan Deposition)
To measure the levels of proteoglycan, an essential chondrocyte cell marker, the Alcian
Blue Staining was performed. Cells were fixed with 100% cold methanol for 5 minutes and then
0.1% Alcian Blue in 0.1M HCl was added overnight. After washing the cells three times with 1x
PBS, the alcian blue was extracted overnight with 6M Guanidine-HCl on an orbital shaker at
4℃. The samples were then read at an absorbance of 595nm.

RNA Isolation (Zymo Research)
Following treatment, cells were harvested on Days 1, 3, and 7. Wells were aspirated of
any media and washed with 1x PBS (ThermoFisher, Waltham MA). Using a cell scraper, the
cells were extracted and transferred to an autoclaved microcentrifuge tube for centrifugation. To
separate pure RNA, the Direct-zol RNA MicroPrep Kit (Zymo Research, Irving CA) was used.
All steps were performed at room temperature with samples kept on ice and centrifuged at
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10,000 x g for 30 seconds, unless specified. The PBS supernatant was aspirated, and the pellet
was resuspended in 350µL of TRI Reagent buffer (Zymo Research, Irving CA). An equal
volume of 350µL of 95-100% ethanol was added to the lysed sample (Zymo Research, Irving
CA). The mixture was transferred into a Zymo-Spin IC Column placed in a collection tube and
centrifuged. The spin column was placed into a new collection tube and the flow-through was
discarded. Next, 400µL of Direct-zol RNA Pre-Wash (Zymo Research, Irving CA) was added to
the column and centrifuged. The flow through was discarded and the above step was repeated.
Then, 700µL of RNA Wash Buffer (Zymo Research, Irving CA) was added to the column and
centrifuged for 1 minute to ensure complete removal of the wash buffer. The column was then
transferred carefully into an RNase-free tube. RNA was then eluted into 15µL of autoclaved
Dnase/Rnase free water and added directly onto the column matrix and centrifuged. The
concentrations and purity of RNA were measured using the BioDrop Duo (Biodrop, Cambridge
UK). The samples were stored in the -80℃ to prevent denaturation.

Reverse Transcriptase
To synthesize cDNA from the RNA isolates, 100ng of each RNA sample was diluted
with Dnase/Rnase free water for a total of 12µL and prepared as the reaction tubes. Depending
on the number of samples, 4µL of Master Mix I made with 2µL of 5mM dNTPs and 2µL of
oligo dTs were added to the sample reaction tubes. The reaction tubes were then vortexed,
centrifuged, secured with fasteners, and placed in a 65℃ MyBlock hot bath (Benchmark
Scientific Inc., Sayreville NJ) for 3 minutes, and returned to ice. Next, 3µL of Master Mix II
made with 2µL of 10x MM-LVRT Buffer (Biolabs, Boston MA) and 1µL of Rnase Inhibitor
(Biolabs, Boston MA) were added to the reaction tubes. The enzyme was added separately with

11

1µL of MM-LVRT (Lucigen, Middleton WI) to the reaction tubes, and then vortexed and
centrifuged. The reaction tubes were then placed in a 42℃ Isotemp water bath (ThermoFisher
Scientific, Hampton NH) for 1 hour. After the incubation, the reaction tubes were spun down
quickly, secured with fasteners, and placed in a 95℃ hot bath for 10 minutes. The reaction tubes
were then allowed to cool to room temperature before using the Biodrop (Biodrop, Cambridge
UK) to quantify the cDNA.

Polymerase Chain Reaction (PCR)
To confirm the presence of cDNA, PCR was ran using GAPDH. First, a 10µM Working
Primer Solution of GAPDH (Invitrogen, Waltham MA) was made from 10µL Forward and 10µL
Reverse primer stocks of 100µM and diluted with 80µL of Dnase/Rnase free water. Then,
Master Mix I was made with 2.5µL 10X Standard Taq Reaction Buffer (Biolabs, Boston MA)
1µL of 10µM dNTPs, 1µL of 10µM GAPDH Working Primer Solution, 17.875µL of
Dnase/Rnase free water, and 0.125µL of Taq DNA Polymerase Enzyme (Biolabs, Boston MA).
Each amount was multiplied by the number samples, and 22.5µL of Master Mix and 2.5µL of
cDNA was added to PCR tubes. The PCR tubes were vortexed and spun down before loading
into the PCR T100 Thermal Cycler (BioRad, Hercules CA). The PCR program for Taq called for
Initial Denaturation of 95℃ for 30 seconds, 30 cycles of 95℃ for 15-30 seconds, 60℃ for 15-60
seconds, 68℃ for 1 minute/kb, Final Extension for 68℃ for 5 minutes, and a hold for 4-10℃.
The PCR samples were then transferred to the -80℃ for storage.
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Table 1: PCR Thermocycler Program

Temperature (℃)
95
Initial Denaturation
95
Denaturation
60
Annealing
68
Extension
68
Final Extension
4
Hold

Time
30 sec
30 sec
30 sec
1 min
5 min
∞

Number of Cycles
30
30
30

DNA Gel Electrophoresis
To verify the success of the RT-preps, a 2% gel was made with 0.5g agarose and 25mL
of Tris-Acetate-EDTA (TAE) Buffer 10X Liquid Concentrate (Hoefer Inc, Hollisten MA).
Agarose, electrophoresis grade (MP Biomedicals, Santa Ana CA) and TAE buffer were
combined in an Erlenmeyer flask, heated for periods of 10-30 seconds in the microwaved, and
swirled until the solution was clear and homogeneous. Once the Horizon 58 Gel Box (Life
Technologies, Carlsbad CA) was properly set up, the agarose solution was poured into the gel
case with an 8-well comb and left to cool for 20-25 minutes. Once the gel was fully solidified,
the comb was carefully removed, and the gel was submerged in 1x TAE buffer. The first well
was loaded with 4µL of DNA Marker 100bp Ladder (Denville Scientific, South Painfield NJ)
followed by 10µL of sample and 5µL of 5x DNA loading dye, which was combined over a
square of parafilm. The EC300XL Electrophoresis Power Supply (ThermoScientific, Waltham
MA) ran at conditions of 90V at 120mA for 1 hour. The gel was then carefully transferred to a
small box and submerged with DI water. The gel was left to shake for 10 minutes with 2-4µL of
Ethidium Bromide Solution (G BioSciences, St. Louis MO). The gels were then imaged on the
FluorChem machine (ProteinSimple, Santa Clara CA) on a clear plate.

13

Quantitative Polymerase Chain Reaction (qPCR)
To amplify cDNA for the gene expression, qPCR was completed. First, cDNA samples
were diluted 1:20 (5µL:95µL Rnase/Dnase free water) and the respective 5µM Working Primer
Solutions were made. After, a Master Mix of 10µL ZymoTaq qPCR PreMix (Irvine, CA), 3µL
5µM Working Primer Mix, 6.5µL Rnase/Dnase free water, and 2.5µL of cDNA sample were
added to a 384-well plate. Volumes of the Master Mix were determined by the number of
samples needed for the experiment.
Table 2: qPCR Thermal and Melt Curve Programs

Temperature (℃)
Time Number of Cycles
Initial Denaturation
95
10 min
40
Denaturation
95
30 sec
40
Annealing
60
30 sec
40
Extension
72
15-30 sec
40
Final Extension
72
7 min
Hold
4
> 4 min

Table 3: Primer Sequences

Oligo Name
B-Actin_R
B-Actin_F
RHEB_F
RHEB_R
KISS1_F
KISS1_R
COL2A1_F
COL2A1_R
RUNX2_F
RUNX2_R

Sequence
GACAGGATGCAGAAGGAGATTACTG
CCACCGATCCACACAGAGTACTT
AAGTCCCGGAAGATCGCCA
GGTTGGATCGTAGGAATCAACAA
GGCTTCTCTTGGTGTGTTCC
TCATTCTGGCAGGAAGAGGC
TGGGTGTTCTATTTATTTATTGTCTTCCT
GCGTTGGACTCACACCAGTTAGT
GACGAGGCAAGAGTTTCACC
GGACCGTCCACTGTCACTTT
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Data Analysis
Data analysis was completed using the SigmaPlot Software version 14.5. One-way or
Two-way ANOVA analyses were performed, and differences were considered significant at (P <
0.05) using the Holm-Sidak test. Other depictions created using BioRender.com .
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Results:

Figure 3: Quantification of Cell Proliferation in Trace Element Treated ATDC5 Cells
MnCl2 displayed a significant increase between insulin and high dose (*P<0.032, n=3).
Increasing concentration of MnCl2 demonstrated positive correlation with Percent Viability.

MnCl2 Affects Cellular Viability
Percent viability of the Low dose increased 0.03-fold when compared to Insulin and 0.38fold of the medium dose when compared to insulin (Figure 1). No statistical difference was
found between the low and medium doses when compared to insulin. However, high dose
MnCl2 was found to be 0.5-fold significant increase when compared to insulin (*P<0.032).
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Figure 4: ALP Activity in Trace Element Treated ATDC5 Cells Over 21 Days
There is a statistically significant interaction between Time and Treatment. (P = <0.001, n=3).
Refer to Tables 4 and 5 for the significant P-values.
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MnCl2 Treatment Stimulates Alkaline Phosphatase Activity
Our data shows that all treatment groups, except high MnCl2, show increased ALP
activity between days 1 and 10 (Figure 4, Tables 4, 5). There were no statistically significant
differences on days 1 to 7. A >1.5-fold significant increase was detected on day 10 when
comparing low and medium MnCl2 to untreated and insulin groups (+P<0.026). When
comparing day 10 low and medium MnCl2 to high MnCl2, there was a 14.5-fold increase
(P<0.001). The high MnCl2 treatment group significantly decreased ALP treatment at all time
points when compared to untreated (*P<0.001 on days 10 and 14, !P=0.022 on day 17). Low and
medium MnCl2 treatments are 2.1-fold and 1.4-fold less than both untreated and insulin-treated
on day 14, respectively (P<0.001). However, on day 21, the low MnCl 2 treatment group had 2.0fold significantly higher ALP levels then both untreated and insulin treatment groups
(^P<0.001).
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Figure 5: Calcium Deposition in ATDC5 Cells Post MnCl2 Treatment
A) Qualitative Staining of ATDC5 Cells with Alizarin Red on D14 and D21 at 4x Magnification
Scale bar measures 500 micrometers.
B) Quantitative Measures of D21 Alizarin Red
Concentrations across all treatments show statistical
significance when compared to untreated cells, (P<0.001, n=3).
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Figure 6: Proteoglycan Deposition in ATDC5 Cells Post MnCl2 Treatment on Days 14 & 21
A) Qualitative Staining of ATDC5 Cells with Alcian Blue on D14 and D21 at 4x Magnification
Scale bar measures 500 micrometers.
B) Proteoglycan Deposition of Trace Elements Treated ATDC5 Cells on Day 14
There was a significant difference between the untreated and insulin
treated groups (*P<0.05, n=3).
C) Proteoglycan Deposition of Trace Elements Treated ATDC5 Cells on Day 21
The treatment groups displayed varying concentrations of proteoglycan deposition with only the
low and medium treatment significant when compared to untreated (*P<0.005, n=2)
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MnCl2 Induces Calcification and Proteoglycan Deposition in ATDC5 Chondrocytes
Low, medium, and high doses clearly show larger amounts of chondrocyte condensation
as visualized by increased red-brown pigment and the large clusters of condensate calcified
nodules when compared to the untreated control (Figure 5A). On day 21, calcification was
quantified, where all treatment groups showed a 4.0-fold significant difference of calcium
deposition when compared to untreated cells (*P<0.001, Figure 5B). Qualitative analysis
(Figure 6A) shows an increase in blue pigmentation when treating chondrocytes with insulin on
both days 14 and 21. Untreated, low MnCl2, medium MnCl2 groups were found to be 1.4-fold
and 0.25-fold significantly less than insulin-treatment on day 14 and day 21, respectively. On
day 21, low and med MnCl2 were 3.0-fold significantly less than the untreated group as well
(*P<0.05, Figure 6C).
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Figure 7: Quantification of Gene Expression Post MnCl2-Treatment Overtime
A) Col2a1 Expression in low and high MnCl2 treated cells shows greatest activity
on Day 1 in comparison to Untreated cells (*P<0.001, #P=0.047, n=2).
B) RUNX2 Expression is increased with MnCl2 and insulin at Day 1,
which decreases overtime to Day 7 (n=2).
C) RHEB Expression shows minimal activity in MnCl2 treated cells.
Insulin is increased compared to treatment groups (n=3).
D) KISS1 Expression in medium and high MnCl2 show decreased
KISS1activity compared to untreated cells. Low MnCl2 shows
heighted KISS1 expression at Day 7 (n=3).
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Characterization of Gene Expression in MnCl2 Treated ATDC5 Cells
When investigating Col2a1 expression on day 1, low MnCl2 was found to have increased
gene expression when compared to untreated, insulin and high MnCl 2 treatment groups
(P<0.001). Day 1 medium MnCl2 also displayed a similar trend against insulin and high MnCl2
(P<0.001, P=0.004). On day 3, Col2a1 expression was most seen upregulated in the insulin
treatment group when compared to the other treatment groups (P<0.001, Figure 7A). Insulin and
MnCl2 treatment groups have increased RUNX2 activity on Day 1, but declined by Day 7
(Figure 7B). MnCl2 -treatments on Days 1, 3, and 7 show little to no expression of RHEB in
ATDC5 cells (Figure 7C). On day 3, insulin treatment shows increased RHEB expression.
KISS1 activity increased in untreated samples between days 1-7. On day 1, a significant
increase in KISS1 expression was found when comparing medium MnCl2 and all other treatment
groups. By day 7, the low MnCl2 group showed 0.27-fold increase in the KISS1 expression
when compared to all other treatment groups (Figure 7D).

23

Discussion & Conclusion:

In this study, it was hypothesized that manganese chloride would have a positive effect
on chondrocyte viability, alkaline phosphatase (ALP) activity, calcium deposition, and
proteoglycan deposition. MnCl2 was found to decrease cellular viability at all concentrations
(0.3µM-30µM) when compared to our untreated control. Our data is similar to Doyle et al who
found that 10µM of manganese chloride inhibited cell viability and differentiation by 50% in
micromass cultures of mouse embryonic limb bud cells using a neutral red biouptake assay (19).
Similarly, Lüthen et al, who studied the cellular behavior of manganese ions on human
osteoblasts in vitro, found that in a manganese concentration-dependent manner human
osteoblast cellular morphology was altered and growth inhibited (20). A neurotoxicity study
conducted by Cardova et al found that prolonged manganese exposure increased ROS and
caspase activity, initiating apoptotic and necrotic cell death of in vivo rat models (21). Thus, the
increased oxidative stress could explain the decrease in cellular viability of our ATDC5 cells.

Interestingly, we found that despite of reductions in cell viability or proliferation the
presence of MnCl2 at low or medium levels had positive effects on calcium deposition. Previous
data supports are finding that lower concentrations of MnCl2 (0.125mg/kg) aids in fracture
healing after day 10 by significantly increasing precent mineralization of tissue (P<0.05) as in
Hreha et al (22). This confirms that MnCl2 treatments can induce the secretion of proper proteins
for endochondral ossification, including calcium. According to Litchfield et al, manganese
concentrations of 50µM or higher inhibit mineralization of primary chondrocytes from broilerstrain chickens, reducing levels of proteoglycan, cell proteins, and collagen synthesis (23).
Regarding proteoglycan deposition, we found the MnCl2 impaired its deposition at as little as
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0.3µM. Similarly, Doyle’s observed fewer proteoglycan-producing nodules in manganeseexposed cultures of mouse embryonic limb bud cells on day 21 (19). Doyle noted that the
number of proteoglycan-producing nodules reduced 50% when comparing 20µM MnCl2 to the
untreated control (19).

Overall, we found that MnCl2 can modulate gene expression of Col2a1, RUNX2, RHEB,
and KISS1. Cells treated with MnCl2 peaked in Col2a1 expression, a marker of MSC
condensation and major component of the ECM on day 1. Through the lens of OA, Kumar et al
investigated inflammation-induced cartilage protection with manganese dioxide (MnO2)
nanoparticles (24). Like our findings, Kumar found that the expression of catabolic genes, such
as Col2a1, were upregulated with the addition of MnO2 nanoparticles (24). Prasadh, who studied
manganese containing alloy extracts cultured with osteoblastic MC3T3-E1 cells, saw an increase
of RUNX2 and ALP expression (25). The upregulation of RUNX2 and ALP reflect hypertrophic
chondrocytes differentiation, mineralization, and endochondral ossification, confirming our ALP
results. Sato, who studied Mn2+ activation on recombinant RHEB proteins that were purified
after expression in E. Coli, RHEB does not activate the catalytic activity of mTOR, but Mn2+can
directly activate mTOR’s subunit, mTORC1, even without RHEB present (26). In terms of
chondrogenesis, the activation of mTORC1 is crucial for embryonic skeletal growth and matrix
production (27). As confirmed by Sato, our data displays a downregulation of RHEB expression
throughout the 7 days of treatment. Interestingly, Sato also found that Insulin activates RHEB
through AKT-dependent phosphorylation of TSC2, which also activates mTORC1 (26). Sato’s
data confirms the increased gene expression of RHEB with our positive control, insulin (26).
According to Srivastava, who investigated KISS1 stimulation with manganese in prepubertal
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female rats, concluded that manganese increased AKT, RHEB, TSC2, and KISS1, which all
serve as activators of the mTOR pathway (18).

In conclusion, MnCl2 reduced cellular viability and proteoglycan deposition, while
increasing ALP activity and calcium deposition. Col2a1expression of MnCl2 treated cells was
statistically significant at the beginning of chondrogenesis, but reduces RUNX2 activity up to
day 7. Further analysis of transcription factors, such as SOX9 and BMPs, can also be reviewed
on the gene and protein level to understand where cellular viability and proteoglycan levels begin
to dwindle. For this, earlier timepoints between 8 hours and 72 hours can be tested, as much of
our data points to either elevated or decreased activity on day 3. Additionally, our results
demonstrated downregulation of RHEB expression, while KISS1 displayed slowly increasing
expression over 7 days. Further experiments investigating manganese as an insulin-mimetic can
be conducted to understand the element’s role in pathway modulation. Previous studies have
explored insulin or IGF treatments improving neurodegenerative Huntington Disease via the
PI3K/AKT/mTOR pathway, and have also revealed that manganese is able to activate many of
the same metabolic kinases, while increasing peripheral and neuronal insulin and IGF-1 levels in
rodent models (28). Also, other studies have confirmed in vitro manganese exposure activates
extracellular signal-related protein kinase-1/2 (ERK1/2) and AKT phosphorylation (21).
Considering this, different activators of the PI3K/AKT/mTOR pathway can be explored to better
understand manganese’s role in chondrogenesis.

26

Supplemental Data:

Figure A: Quantification of Cell Proliferation in Trace Element Treated MC3T3-E1 Cells
Manganese chloride treatments showed no statistical significance on the
murine osteoblast cell line, MC3T3-E1 (n=6).
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Table 4: Comparison of Significant Treatments of ALP Activity Per Day
Day 10
Comparison
Low vs. High
Medium vs. High
Positive vs. High
Untreated vs. High
Low vs. Untreated
Low vs. Positive

P-Value
<0.001
<0.001
<0.001
<0.001
0.026
0.04

Day 14
Comparison
Untreated vs. High
Positive vs. High
Medium vs. High
Untreated vs. Low
Positive vs. Low
Low vs. High
Untreated vs. Medium
Positive vs. Medium
Medium vs. Low

Day 17
P-Value
Comparison
<0.001
Positive vs. High
<0.001
Medium vs. High
<0.001
Low vs. High
<0.001 Positive vs. Untreated
<0.001 Medium vs. Untreated
<0.001
Untreated vs. High
0.004
0.008
0.044

P-Value
<0.001
<0.001
<0.001
<0.001
0.004
0.022

Day 21
Comparison
Low vs. High
Low vs. Medium
Low vs. Positive
Low vs. Untreated
Untreated vs. High
Positive vs. High
Medium vs. High

P-Value
<0.001
<0.001
<0.001
<0.001
<0.001
0.006
0.027

Table 5: Comparison of Significant Timepoints of ALP Activity Per Treatment
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Table 6: Statistically Significant Treatments Within Timepoints

COL2a1
Day 1
Comparison
Low vs. Insulin
Low vs. High
Medium vs. Insulin
Low vs. Untreated
Untreated vs. Insulin
Medium vs. High
Low vs. Medium
Untreated vs. High

P-Value
<0.001
<0.001
<0.001
<0.001
0.005
0.004
0.009
0.047

Day 3
Comparison
P-Value
Insulin vs. Low
<0.001
Insulin vs. Medium <0.001
Insulin vs. High
<0.001
Insulin vs. Untreated 0.001
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